Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple habit tracker help prevent SIDS?

NCT ID NCT07779512

Prevention Sponsor: State University of New York at Buffalo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether adding a daily habit tracker to a brief safe sleep education video helps caregivers of infants up to 4 months old stick to recommended safe sleep practices, like placing babies on their backs and using a crib without soft bedding. Half of the caregivers will watch the video and receive a handout, while the other half will also track their baby's sleep habits daily for four weeks. The goal is to see if the habit tracker improves adherence to all four key safe sleep guidelines, which could lower the risk of SIDS and other sleep-related infant deaths.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Safe sleep education video plus a daily habit tracking form
What this could lead to
If effective, this approach could give hospitals a simple, low-cost tool to help families consistently follow safe sleep guidelines, potentially reducing sleep-related infant deaths.
What could go wrong
The study is relatively small and relies on caregivers reporting their own behavior, which may not reflect real-world adherence. The habit tracker may not provide lasting improvement beyond the four-week study period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 214 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 3 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Legal guardian of infants ages 0 to \< 4 months , evaluated in GCHB PED ages 0 to \< 4 months * English speaking primary caregiver of infant * Infant ED triaged ESI 2-5 * Able to complete follow-up surveys via phone or email * Family not completely adherent to all 4 pre-determined safe sleep guideline recommended behaviors. If they are adherent to 3 out of 4 guidelines, they are eligible for the study. Exclusion Criteria: * Infants requiring intensive interventions where PED education is not feasible * Non-English-speaking primary caregiver * Legal guardian unable to complete baseline survey or provide follow-up contact * Legal guardian completely adherent to safe sleep guidelines

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infant safe sleep practices are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sudden Infant Death sudden unexpected infant death

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infant safe sleep practices SIDS

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Golisano Children's Hospital of Buffalo

    Buffalo, New York, 14203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.